NovelStem International Corp

A biotechnology holding company focused on stem cell-based diagnostic technology for cancer treatment optimization.

Venture Capital Active Boca Raton, United States Est. 1993
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$5.0M
total disclosed, rounds participated
Stages
—

About

NovelStem International Corp. is a publicly traded SEC reporting company that was formerly known as Hollywood Media Corp. before changing its name in September 2018. The company's primary focus shifted from a media business to stem cell-based diagnostics for cancer chemotherapies. NovelStem's principal assets were a significant equity interest in NewStem Ltd., an Israeli biotech company, and a 50% equity interest in a joint venture named NetCo Partners. NovelStem aimed to develop and commercialize diagnostic technology that could predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. However, in May 2025, NovelStem announced that NewStem Ltd. ceased operations and was liquidated due to insufficient funding, with its technology reverting to Yissum, The Hebrew University of Jerusalem's technology-transfer company. NovelStem expects to recover some value from its investment in NewStem through its right to share up to $3.75M of future monetization of the NewStem IP platform. The company is currently focused on seeking a merger partner and reducing outstanding debt.

Portfolio · 1

NewStem
Precision Medicine Therapeutics
2 rounds $5.0M committed Latest: 2019-12

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is NovelStem International Corp's primary investment focus by sector?
NovelStem International Corp primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
Can you name a notable portfolio company of NovelStem International Corp?
A notable portfolio company of NovelStem International Corp is NewStem, which operates in the Precision Medicine Therapeutics space.
What is the typical investment stage for NovelStem International Corp?
NovelStem International Corp primarily invests in the Seed stage, with both initial and follow-on investments occurring at this stage.
What was NovelStem International Corp's most recent investment activity?
NovelStem International Corp's most recent investment activity was in December 2019, according to startupim data.
What was the first investment made by NovelStem International Corp?
NovelStem International Corp made its first investment in July 2018, according to startupim data.
What is the typical check size for NovelStem International Corp?
NovelStem International Corp typically invests in the range of $1M to $4M.
Has NovelStem International Corp had any exits?
According to startupim data, NovelStem International Corp has not recorded any exits.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded1993-1